Pharma Resource Group, Inc

Pharma Resource Group, Inc. , based in Royersford, US, excels in providing product development and manufacturing solutions, primarily for the Biotech, Medical Device, and Pharmaceutical sectors, helping clients navigate complex market entry challenges. Pharma Resource Group, Inc. was founded in 2007 in Royersford, US, specializing in product development and commercial manufacturing within various life science sectors.

The company is noted for its singular deal completed in 2026, marking a strategic pivot in its business operations. The firm has not publicly disclosed any subsidiaries or parent companies. Pharma Resource Group (PRG) specializes in comprehensive product development, commercial manufacturing, and insourcing services tailored for the Biotech, Consumer, Medical Device, Nutraceutical, Over-the-Counter (OTC), and Ethical Pharmaceutical sectors. Their offerings include a state-of-the-art Innovation, Product Development, and GMP Commercial Manufacturing Center, facilitating the transformation of ideas into market-ready products.

PRG services a diverse client base, including entrepreneurs, innovators, start-ups, and established Fortune 100 companies, addressing challenges such as budget constraints and regulatory hurdles, while ensuring every idea can achieve market viability. The company's operations extend across North America and Europe, enabling it to effectively service a global clientele. Pharma Resource Group's revenue model is based on providing tailored solutions through project-based engagements on a B2B level. Clients engage PRG for specific services, such as product development and manufacturing, often under collaborative agreements.

This model allows clients access to PRG's resources without facing minimum order quantities, facilitating commercialization efforts. Pricing plans are contingent on project scope and complexity, emphasizing cost-effective solutions aligned with client needs. PRG's strategic partnerships with various industry players enhance its revenue generation capabilities while ensuring adherence to high-quality service and compliance. In April 2026, Pharma Resource Group, Inc.

was acquired by Pinnaql, a portfolio company of LSOMS Holdings, L. P. and 3 Boomerang Capital. The acquisition, with undisclosed financial terms, aims to enhance Pinnaql's development and accelerate growth.

The acquisition is expected to facilitate the launch of new products, although specific product details and release dates have not been disclosed. Expansion plans aim to penetrate new markets, particularly in North America and Europe, leveraging the recent funding to support these initiatives.